161
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Correlation Between Fibrinogen/Albumin and Diabetic Peripheral Neuropathy

, , , , ORCID Icon, & show all
Pages 2991-3005 | Received 25 Jun 2023, Accepted 16 Sep 2023, Published online: 27 Sep 2023

References

  • Reed J, Bain S, Kanamarlapudi V. A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives. Diabetes Metab Syndr Obes. 2021;14:3567–3602. doi:10.2147/DMSO.S319895
  • Li Y, Teng D, Shi X, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study. BMJ. 2020;369:m997. doi:10.1136/bmj.m997
  • Tesfaye S, Selvarajah D. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes Metab Res Rev. 2012;28(Suppl 1):8–14. doi:10.1002/dmrr.2239
  • Gylfadottir SS, Itani M, Krøigård T, et al. Diagnosis and prevalence of diabetic polyneuropathy: a cross-sectional study of Danish patients with type 2 diabetes. Eur J Neurol. 2020;27(12):2575–2585. doi:10.1111/ene.14469
  • Boulton AJ, Vinik AI, Arezzo JC, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005;28(4):956–962. doi:10.2337/diacare.28.4.956
  • Lapin BR, Pantalone KM, Milinovich A, et al. Pain in patients with type 2 diabetes-related polyneuropathy is associated with vascular events and mortality. J Clin Endocrinol Metab. 2020;105(9):dgaa394. doi:10.1210/clinem/dgaa394
  • Wolberg AS, Sang Y. Fibrinogen and factor XIII in venous thrombosis and thrombus stability. Arterioscler Thromb Vasc Biol. 2022;42(8):931–941. doi:10.1161/ATVBAHA.122.317164
  • Sun J, Han K, Xu M, et al. Blood viscosity in subjects with type 2 diabetes mellitus: roles of hyperglycemia and elevated plasma fibrinogen. Front Physiol. 2022;13:827428. doi:10.3389/fphys.2022.827428
  • Chen QF, Cao D, Ye TT, Deng HH, Zhu H. Peripheral arterial disease in type 2 diabetes is associated with an increase in fibrinogen levels. Int J Endocrinol. 2018;2018:3709534. doi:10.1155/2018/3709534
  • Zhu Y, Cai X, Liu Y, et al. Serum albumin, but not bilirubin, is associated with diabetic chronic vascular complications in a chinese type 2 diabetic population. Sci Rep. 2019;9(1):12086. doi:10.1038/s41598-019-48486-6
  • Kayapinar O, Ozde C, Kaya A. Relationship between the reciprocal change in inflammation-related biomarkers (fibrinogen-to-albumin and hscrp-to-albumin ratios) and the presence and severity of coronary slow flow. Clin Appl Thromb Hemost. 2019;25:1076029619835383. doi:10.1177/1076029619835383
  • Huang R, Dai Q, Chang L, et al. The association between fibrinogen-to-albumin ratio (FAR) and adverse prognosis in patients with acute decompensated heart failure at different glucose metabolic states. Cardiovasc Diabetol. 2022;21(1):241. doi:10.1186/s12933-022-01662-x
  • Li B, Deng H, Lei B, Chen L, Zhang X, Sha D. The prognostic value of fibrinogen to albumin ratio in malignant tumor patients: a meta-analysis. Front Oncol. 2022;12:985377. doi:10.3389/fonc.2022.985377
  • Wang K, Xu W, Zha B, Shi J, Wu G, Ding H. Fibrinogen to albumin ratio as an independent risk factor for type 2 diabetic kidney disease. Diabetes Metab Syndr Obes. 2021;14:4557–4567. doi:10.2147/DMSO.S337986
  • Teo ZL, Tham YC, Yu M, et al. Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis. Ophthalmology. 2021;128(11):1580–1591. doi:10.1016/j.ophtha.2021.04.027
  • Abuhay HW, Yenit MK, Wolde HF. Incidence and predictor of diabetic foot ulcer and its association with change in fasting blood sugar among diabetes mellitus patients at referral hospitals in Northwest Ethiopia, 2021. PLoS One. 2022;17(10):e0274754. doi:10.1371/journal.pone.0274754
  • Ahmed AM, Hussein A, Ahmed NH. Diabetic autonomic neuropathy. Saudi Med J. 2000;21(11):1034–1037.
  • Li Z, Gao Y, Jia Y, Chen S. Correlation between hemoglobin glycosylation index and nerve conduction velocity in patients with type 2 diabetes mellitus. Diabetes Metab Syndr Obes. 2021;14:4757–4765. doi:10.2147/DMSO.S334767
  • Li C, Wang W, Ji Q, et al. Prevalence of painful diabetic peripheral neuropathy in type 2 diabetes mellitus and diabetic peripheral neuropathy: a nationwide cross-sectional study in mainland China. Diabetes Res Clin Pract. 2023;198:110602. doi:10.1016/j.diabres.2023.110602
  • Janghorbani M, Rezvanian H, Kachooei A, et al. Peripheral neuropathy in type 2 diabetes mellitus in Isfahan, Iran: prevalence and risk factors. Acta Neurol Scand. 2006;114(6):384–391. doi:10.1111/j.1600-0404.2006.00716.x
  • Alkhatatbeh M, Abdul-Razzak KK. Neuropathic pain is not associated with serum vitamin D but is associated with female gender in patients with type 2 diabetes mellitus. BMJ Open Diabetes Res Care. 2019;7(1):e000690. doi:10.1136/bmjdrc-2019-000690
  • Mosesson MW, Siebenlist KR, Meh DA. The structure and biological features of fibrinogen and fibrin. Ann NY Acad Sci. 2001;936:11–30. doi:10.1111/j.1749-6632.2001.tb03491.x
  • Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost. 2005;3(8):1894–1904. doi:10.1111/j.1538-7836.2005.01365.x
  • Soma P, Pretorius E. Interplay between ultrastructural findings and atherothrombotic complications in type 2 diabetes mellitus. Cardiovasc Diabetol. 2015;14:96. doi:10.1186/s12933-015-0261-9
  • Sugimoto MA, Ribeiro ALC, Costa BRC, et al. Plasmin and plasminogen induce macrophage reprogramming and regulate key steps of inflammation resolution via annexin A1. Blood. 2017;129(21):2896–2907. doi:10.1182/blood-2016-09-742825
  • Li XH, Guan LY, Lin HY, et al. Fibrinogen: a marker in predicting diabetic foot ulcer severity. J Diabetes Res. 2016;2016:2358321. doi:10.1155/2016/2358321
  • Kotbi S, Mjabber A, Chadli A, et al. Correlation between the plasma fibrinogen concentration and coronary heart disease severity in Moroccan patients with type 2 diabetes. Prospective study. Ann Endocrinol. 2016;77(5):606–614. doi:10.1016/j.ando.2015.02.004
  • Erem C, Hacihasanoglu A, Celik S, et al. Coagulation and fibrinolysis parameters in type 2 diabetic patients with and without diabetic vascular complications. Med Princ Pract. 2005;14(1):22–30. doi:10.1159/000081919
  • Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial. 2004;17(6):432–437. doi:10.1111/j.0894-0959.2004.17603.x
  • Faure P, Wiernsperger N, Polge C, Favier A, Halimi S. Impairment of the antioxidant properties of serum albumin in patients with diabetes: protective effects of metformin. Clin Sci. 2008;114(3):251–256. doi:10.1042/CS20070276
  • Greco C, Nascimbeni F, Carubbi F, Andreone P, Simoni M, Santi D. Association of Nonalcoholic Fatty Liver Disease (NAFLD) with peripheral diabetic polyneuropathy: a systematic review and meta-analysis. J Clin Med. 2021;10(19):4466. doi:10.3390/jcm10194466
  • Onoprienko A, Hofstetter G, Dorittke T, et al. The prognostic value of the Fibrinogen-Albumin-Ratio Index (FARI) in patients with advanced vulvar cancer. J Pers Med. 2022;12(11):1882. doi:10.3390/jpm12111882
  • Zhu Y, Tao S, Zhang D, et al. Association between fibrinogen/albumin ratio and severity of coronary artery calcification in patients with chronic kidney disease: a retrospective study. PeerJ. 2022;10:e13550. doi:10.7717/peerj.13550
  • Ding Y, Xue L. The potential value of fibrinogen to albumin ratio (FAR) in the assessment of inflammation in spondyloarthritis. BMC Musculoskelet Disord. 2022;23(1):864. doi:10.1186/s12891-022-05797-6
  • Zhai M, Cao S, Lu J, Xu H, Xia M, Li Z. The relationship between the fibrinogen to albumin ratio and early outcomes in patients with acute pontine infarction. Clin Appl Thromb Hemost. 2022;28:10760296211067260. doi:10.1177/10760296211067260
  • Galiero R, Caturano A, Vetrano E, et al. Peripheral neuropathy in diabetes mellitus: pathogenetic mechanisms and diagnostic options. Int J Mol Sci. 2023;24(4):3554. doi:10.3390/ijms24043554
  • Kellogg AP, Wiggin TD, Larkin DD, Hayes JM, Stevens MJ, Pop-Busui R. Protective effects of cyclooxygenase-2 gene inactivation against peripheral nerve dysfunction and intraepidermal nerve fiber loss in experimental diabetes. Diabetes. 2007;56(12):2997–3005. doi:10.2337/db07-0740
  • Ziegler D, Papanas N, Schnell O, et al. Current concepts in the management of diabetic polyneuropathy. J Diabetes Investig. 2021;12(4):464–475. doi:10.1111/jdi.13401
  • Siao P, Kaku M. A clinician’s approach to peripheral neuropathy. Semin Neurol. 2019;39(5):519–530. doi:10.1055/s-0039-1694747
  • Ziegler D, Papanas N, Zhivov A, et al. Early detection of nerve fiber loss by corneal confocal microscopy and skin biopsy in recently diagnosed type 2 diabetes. Diabetes. 2014;63(7):2454–2463. doi:10.2337/db13-1819
  • Rebelos E, Tentolouris N, Jude E. The role of vitamin D in health and disease: a narrative review on the mechanisms linking vitamin d with disease and the effects of supplementation. Drugs. 2023;83(8):665–685. doi:10.1007/s40265-023-01875-8
  • Gylfadottir SS, Itani M, Kristensen AG, et al. Assessing corneal confocal microscopy and other small fiber measures in diabetic polyneuropathy. Neurology. 2023;100(16):e1680–e1690. doi:10.1212/WNL.0000000000206902